Skip to content

Effectiveness of camouflaged syringe in reducing dental anxiety and pain during maxillary local anesthesia in children

Effectiveness of camouflaged syringe in reducing dental anxiety and pain during maxillary local anesthesia in children aged 6–9 years: a randomized controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN51025476
Enrollment
70
Registered
2025-07-24
Start date
2023-12-02
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental pain and anxiety Oral Health

Interventions

The sample was collected from children who were referred to the Department of Paediatric Dentistry at the Faculty of Dentistry, Damascus University. Participation in the study was openly voluntary, an

Sponsors

Damascus University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 9 Years

Inclusion criteria

Inclusion criteria: 1. Healthy children aged 6 to 9 years requiring dental treatment involving maxillary infiltration local anesthesia 2. Children with no previous dental experience 3. Children who had not received any sedative or analgesic medication within three hours before the appointment 4. Children who demonstrated positive behavior according to the Frankl Behavior Rating Scale

Exclusion criteria

Exclusion criteria: 1. Children unable to communicate effectively 2. Children with physical or cognitive disabilities 3. Uncooperative children exhibiting disruptive behavior 4. Children with acute pulpitis or severe dental abscess 5. Children whose legal guardians refused to provide consent

Design outcomes

Primary

MeasureTime frame
1. Dental anxiety is measured using the Facial Image Scale (FIS) at baseline (before any intervention) and after behavioral management using the Tell-Show-Do technique and introduction to either the camouflaged or conventional syringe, but before administration of topical anesthesia 2. Pulse rate is measured using a finger pulse oximeter at baseline (while seated in the dental chair), after behavioral management and syringe introduction, and one minute after completion of the local anesthetic injection 3. Pain perception is measured using the Face, Legs, Activity, Cry, Consolability (FLACC) scale during the administration of local anesthesia

Secondary

MeasureTime frame
There are no secondary outcome measures

Countries

Syria

Contacts

Public ContactMawia Karkoutly
mawiamaherkarkoutly@hotmail.com+963 992647528

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 14, 2026